Research on predictive factors in gynecological cancers
Predictive Clinical and Biological Parameters in Gynecological Cancer - GC-BIO-IPC 2013-010
NA · Institut Paoli-Calmettes · NCT01977274
This study is trying to find out which clinical and biological factors can help predict how well patients with ovarian, endometrial, and cervical cancers will do, by looking at their genetic and protein information.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Institut Paoli-Calmettes (other) |
| Locations | 1 site (Marseille) |
| Trial ID | NCT01977274 on ClinicalTrials.gov |
What this trial studies
This study investigates the clinical and biological parameters that may predict outcomes in patients with gynecological cancers, specifically focusing on ovarian, endometrial, and cervical cancers. It aims to analyze genomic, proteomic, and mutation data to identify potential predictive markers. The study involves patients who are suspected of having gynecological cancer and will collect data through clinical assessments and biological samples. The goal is to enhance understanding of these cancers and improve patient management.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 who have a suspicion of gynecological cancer and can provide informed consent.
Not a fit: Patients with non-gynecological cancers or those in emergency situations may not benefit from this study.
Why it matters
Potential benefit: If successful, this research could lead to better prediction of treatment outcomes and personalized care for patients with gynecological cancers.
How similar studies have performed: Other studies have shown promise in identifying predictive factors in cancer, suggesting that this approach may yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * gynecological cancer suspicion * age \> 18 * signed informed consent Exclusion Criteria: - emergency Exclusion criteria after histological exam Any diagnosis that is not a gynecological cancer (ovarian, cervix, endometrium).
Where this trial is running
Marseille
- Institut Paoli Calmettes — Marseille, France (RECRUITING)
Study contacts
- Study coordinator: Dominique GENRE, MD
- Email: drci.up@ipc.unicancer.fr
- Phone: 33491223778
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Ovarian Cancer, Endometrium Cancer, Cervix Cancer, ovarian, endometrium, cervix cancer